TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 17, 2026 · EVP, CHIEF COMMERCIAL OFFICER Heerma Peter sold 283.19K shares at $63.06/share ($17.9M); exercised options for 516.38K shares

EVP, CHIEF COMMERCIAL OFFICER Heerma Peter sold 283.19K shares at $63.06/share ($17.9M); exercised options for 516.38K shares

xslF345X06/form4-09182026_010901.xml

xslF345X06/form4-09182026_010901.xmlSEC.gov

Graphics and non-inline formats (not embedded below).